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ABSTRACT
Background Chronic aflatoxin (AF) exposure has been 
shown to occur at high levels in children from sub- 
Saharan Africa (SSA), and has been associated with 
growth retardation and immune dysfunction. Our objective 
was to investigate the impact of AF exposure on immune 
development in early infancy using thymic size and 
antibody (Ab) response to vaccination as indicators of 
immune function.
Methods A total of 374 infants born between May 2011 
and December 2012 were enrolled into the current study. 
These infants were recruited from a larger, randomised 
trial examining the impact of nutritional supplementation 
of mothers and infants on infant immune development (the 
Early Nutrition and Immune Development Trial). Thymic 
size (Thymic Index, TI) was measured by sonography at 
1 week, 8 weeks, 24 weeks and 52 weeks of infant age. 
Infants were given the diphtheria–tetanus–pertussis (DTP) 
vaccine at 8 weeks, 12 weeks and 16 weeks of age, and 
Ab responses to each vaccine measured at 12 weeks and 
24 weeks of age. AF- albumin (AF- alb) adduct levels in 
infant blood were measured by ELISA as the biomarker of 
AF exposure.
Results The geometric mean (GM) level of AF- alb 
increased with age. Only half of infants had detectable 
AF- alb with a GM of 3.52 pg/mg at 24 weeks, increasing 
to 25.39 pg/mg at 52 weeks, when 98% of infants had 
AF- alb >limit of detection. Significant negative association 
of AF- alb level with TI was seen in infants during the first 
24 weeks, especially at 8 weeks of age (p<0.001), which 
is the time point of fastest thymus growth. There were no 
associations between AF exposure level and Ab response 
to pertussis and tetanus, but a significant positive 
correlation was observed between AF- alb level and Ab titre 
to diphtheria (p<0.005).
Conclusions High levels of AF exposure during early 
infancy may impact on infant immune development.
Trial registration number ISRCTN49285450.
INTRODUCTION
Aflatoxin (AF) is a mycotoxin produced 
mainly by Aspergillus flavus and Aspergillus 
parasiticus fungi that frequently contaminate 
crops in tropical and subtropical areas. It 
poses a great health risk to populations living 
in sub- Saharan Africa (SSA), especially in 
regions where groundnuts and/or maize are 
the staple foods.1 Exposure to AF can begin 
in utero through transplacental exposure, 
continue in early infancy through breast 
feeding and increase as children are weaned 
onto family foods, such as maize porridge or 
peanut sauces.2 Populations in the Gambia 
are at a high risk of AF exposure through 
food consumption.3–7
AF is a human liver carcinogen,8 and has 
also been associated with childhood growth 
faltering.9 10 An inverse relationship has been 
reported between AF- albumin adduct (AF- 
alb) levels in pregnant women and subsequent 
infant growth5 as well as between AF- alb and 
growth in infants below 2 years old,7 10 and 
high levels of AF lysine were associated with 
stunting and severe malnutrition in children 
in Nigeria,11 and with underweight children 
in Kenya.12 Data from animal studies suggests 
that AF modulates the immune response at 
the level of innate cell functions, antibody 
(Ab) production, lymphocyte activation and 
proliferation and regulation of cytokine/
chemokine expression, but there have been 
few studies on the impact of AF on immune 
function in humans.13 14 A reduction of sali-
vary IgA expression15 and lower percentage 
of lymphocytes16 17 in children with high 
AF exposure have been reported. A greater 
Strengths and limitations of this study
 ► The study was embedded within a clinical trial (Early 
Nutrition and Immune Development), which reduced 
selection bias of subjects.
 ► The subjects were part of a cohort naturally exposed 
to aflatoxin (AF) through their diet, which allowed for 
multiple time point sampling.
 ► The AF exposure was measured using a validated 
biomarker, which allows better estimation of expo-
sure compared with food intake estimates.
 ► A limitation of the study is that AF exposure in utero 
(ie, by measuring biomarker levels in the pregnant 
women) was not performed.
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understanding of the impact of chronic AF exposure 
during infancy and early childhood on immune system 
development is required.
The thymus is a primary lymphoid organ, essential 
for the development and differentiation of T lympho-
cytes. Thymic Index (TI; a derived estimate of thymic 
volume) measured sonographically has been used as an 
indicator of immune development in infants. Impaired 
thymic development in infancy has been associated with 
morbidity and mortality in childhood in Guinea- Bissau 
and Bangladesh,18–20 indicating a functional consequence 
of poor early thymic development.
The effect of chronic AF exposure on humoral immu-
nity is less consistent in animal and human studies.21 22 
A study conducted in infants in the Gambia reported a 
weak but significant positive association between the level 
of AF- alb and pneumococcal Ab titres.15 Combined DTP 
(diphtheria, tetanus and pertussis) vaccine has been 
involved in the Expanded Programme on Immunisation 
(EPI), which was established in 1977 by the WHO and is 
estimated to prevent 2–3 million deaths in children every 
year.
The aim of the current study was to determine the 
impact of AF exposure in early infancy on thymus growth 
and altered Ab response to combined DTP vaccination.
METHODS
Study subjects
The current substudy into the effects of AF exposure 
on immune parameters was embedded within the Early 
Nutrition and Immune Development (ENID) trial. Full 
details of the ENID trial protocol have been published.23 
The primary objective of the ENID trial was to investi-
gate whether combined prenatal (protein energy and/or 
micronutrients) and infant (micronutrient) nutritional 
supplements could improve child’s immune develop-
ment. In total, 875 pregnant women from the West Kiang 
region of the Gambia were recruited into the ENID trial. 
In the current study, blood samples were taken from all 
children born into the ENID trial between May 2011 and 
December 2012 (N=374), to give sufficient power to assess 
impact of AF exposure on TI and Ab response.
At enrolment into the ENID trial, pregnant women 
were randomly allocated to four different trial arms: iron–
folate (FeFol), multiple micronutrients (MMN), protein 
energy (PE) combined with FeFol and PE combined 
with MMN. Supplementation continued until delivery. 
From 6 months to 12 months of age, infants were further 
randomised into two supplementation arms: lipid- based 
nutritional supplementation (LNS) or LNS+MMN. 
Compliance of the supplementation was also recorded, 
through weekly interview. Due to the rolling randomis-
ation into supplementation groups on enrolment, the 
children from whom samples were used in the current 
study were randomised into the various groups at approx-
imately equal numbers (table 1).
For the current analysis, anthropometric measurements 
collected at 1 week, 8 weeks, 24 weeks and 52 weeks of 
infant age and infant serum samples collected at 12 weeks, 
24 weeks and 52 weeks of age were used. Infant morbidity 
and feeding practices were recorded by field assistants 
who visited the children weekly at home. Morbidity ques-
tionnaires collected specific data on any episodes of diar-
rhoea, rapid breathing, vomiting, cough or fever or other 
symptoms during previous 7 days. At the same weekly visit, 
data on infant feeding practices (breastfeeding practices 
and introduction of non- breast milk foods) were also 
collected, using a standardised questionnaire.
Table 1 Characteristics of children in the current study
Variable n Mean±SD/n (%)
Gender, n (%) 374
Male 192 (51.3)
Female 182 (48.7)





Mother’s education, n (%) 352
<1 year formal education 235 (66.8)
>1 year formal education 117 (33.2)
Birth weight (kg) 335 3.0±0.4
Birth length (cm) 335 49.7±2.0
Age of introduction of non- 
breast milk foods (weeks)
<6 months 248 4.6±1.3
>6 months 125 6.2±0.1
Morbidity
Sum of first 12 weeks of life 360 8.3±11.0








Infant supplementation group 
(6 months), n (%)
374
LNS+MMN 192 (51.3)
LNS only 182 (48.7)
AF- alb (pg/mg) GM (95% CI)
Week 24 352 3.52 (3.15 to 3.94)
Week 52 331 25.39 (22.37 to 28.82)
AF- alb, alfatoxin- albumin; FeFol, iron–folate; GM, geometric 
mean; LNS, lipid- based nutritional supplementation; MMN, 
multiple micronutrients; PE, protein energy.
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Thymus size assessment
Thymus size of infants was assessed sonographically at 1 
week, 8 weeks, 24 weeks and 52 weeks of age using a vali-
dated method.24 The transverse diameter of the thymus 
and the sagittal area of its largest lobe were detected and 
multiplied to give a volume- related TI. Full details of 
the TI measurements of the ENID trial can be found in 
Moore et al.25
Ab response to vaccination assessment
All infants were immunised in accordance with the 
Gambia EPI programme.23 Three injections of combined 
DTP were given to children at week 8, week 12 and week 
16. Venous blood samples collected from infants at 12 
weeks and 24 weeks and were used to determine the Ab 
response to vaccination. A multiple immunoassay based 
on Luminex xMAP technology was used to detect serum- 
specific IgG Ab responses against diphtheria toxoid, 
pertussis toxin and tetanus toxin.26 27 Full details of the 
outcomes (Ab response to vaccination) of the ENID trial 
can be found in Okala et al.28
AF exposure measurement
AF- alb levels in serum taken at 24 weeks and 52 weeks 
of age were measured at the University of Leeds using 
an ELISA method29 that has been previously validated 
against dietary intake.30 In brief, this analysis is performed 
in four steps: albumin extraction and quantification, 
hydrolysis of albumin with pronase, purification of AF- alb 
residues and the competitive ELISA. The ELISA involves 
the premixing of standards, samples or controls with the 
rabbit anti- AF- Cl2- BSA polyclonal Ab, followed by compet-
itive ELISA in which remaining unbound antibody can 
bind to AF ovalbumin conjugates coated on the surface 
of the ELISA plate well. After washing, the bound primary 
Ab is detected by incubation with an enzyme- labelled goat 
anti- rabbit IgG secondary Ab. Control samples at four 
known concentrations of AF- alb were examined along-
side each batch of samples.
Samples were measured at least twice, in triplicate each 
time, on two different days. Only results with a coefficient 
of variation less than 25% were accepted. The limit of 
detection (LOD) of the assay was 3 pg/mg albumin. The 
AF- alb level in samples less than LOD were assigned a 
value of 1.5 pg/mg for statistical analyses.
Statistical analysis
Statistical analysis was performed using STATA V.15 
(StataCorp LP). Distribution of AF- alb level, TI and Ab 
response to vaccination data were skewed and were, 
therefore, log transformed prior to further analysis. Ab 
fold change was calculated as the Ab level at 24 weeks 
divided by Ab level at 12 weeks. Results were divided into 
low and high AF exposure groups at both 24 weeks and 
52 weeks based on the median of AF- alb level at each time 
point. Student’s t- test was used to compare the association 
of parameters in different seasons or low/high AF expo-
sure level groups.
For other covariates, the season of sampling was cate-
gorised as rainy and dry seasons based on the date of TI 
measurement and blood sample collection for Ab and 
AF- alb analysis. There is a distinct seasonal pattern in the 
Gambia with a period of rainfall from July to October 
(rainy season) and a long dry season between November 
and June. The age (months) of introduction of non- breast 
milk foods to infants were recorded. Infant morbidity was 
coded as sum of the number of morbidity episodes (diar-
rhoea, vomiting, cough, rapid breathing and fever).
Relationships between AF- alb level and TI or Ab titre 
were explored using ordinary least squares regression 
for individual time points, or random effects model for 
the pooling data of all time points. Data are presented 
in different models for TI and Ab titres. The correlation 
between AF- alb level and TI was analysed as model 1: 
unadjusted; model 2: adjusted for infant size (length), 
sex and season at TI measurement; model 3: adjusted 
for infant size (length), season at TI measurement, sex 
and maternal supplement groups (for age ≤24 weeks) or 
both maternal and infants supplement groups (for age at 
52 weeks). The correlation between AF- alb level and Ab 
response was analysed as model 1: unadjusted; model 2: 
adjusted for weight for height z- score (WHZ) and season 
of sample collection; and model 3: adjusted for WHZ and 
season of sample collection, sex, maternal supplement 
groups, haemoglobin (Hb) levels and morbidity.
Consent to participate
Written informed consent was obtained from all 
participants.
Patient and public involvement
Patients or the public were not involved in the design, 
conduct, reporting or dissemination plans of our research.
RESULTS
A total of 800 live born infants were delivered into the 
main ENID trial.25 For the current substudy, 374 infants 
were included. Table 1 summarises the characteristics of 
the participants in the current substudy. More than half of 
mothers (67%) had less than 1 year of formal education. 
Twenty five out of 374 (6.7%) children were born with a 
low birth weight (<2500 g). The mean (SD) duration of 
exclusive breast feeding was 5.2 months (1.3 months).
AF exposure
The geometric mean (GM) level of AF- alb was 3.52 pg/
mg at 24 weeks of age and increased to 25.39 pg/mg at 
52 weeks with 52% and 2% of samples having levels lower 
than the LOD (3 pg/mg) at the 24 weeks and 52 weeks 
age point, respectively. Seasonal variations were observed 
in the exposure (figure 1) with around twofold higher 
levels of AF- alb determined in samples collected during 
the dry season compared with the rainy season at both 
24 weeks and 52 weeks of age (GM 24 weeks: 2.5 pg/mg 
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vs 4.3 pg/mg, p<0.0001; 52 weeks: 19.3 pg/mg vs 35.5 pg/
mg, p<0.0001).
Thymic Index
Thymus growth showed an upward trend during the first 
24 weeks of age (table 2). A significant increase was shown 
from birth to 8 weeks of age and reached maximum size 
at 24 weeks, followed by a decrease at 52 weeks. Seasonal 
variations were also identified in TI, with the TI values 
measured during the dry season being slightly higher 
than those measured in the rainy season at all time points, 
but this difference was only statistically significant in 
infants when measured at 8 weeks of age (mean: 14.3 cm3 
vs 13.3 cm3, p=0.0136) (figure 2).
Ab response to DTP vaccination
The Ab response to vaccination increased significantly 
at 24 weeks of age compared with 12 weeks (table 2). 
For pertussis, the protective Ab titres were detected in 
69.3% of infants after the first dose, increasing to 96.0% 
Table 2 Mean level of TI and GM level of Ab response to vaccination in the ENID trial and the current substudy
Current substudy ENID trial
n GM (95% CI)/mean±SD/(%)* n GM (95% CI)/ean±SD/(%)*
TI (cm3)
Week 1 371 9.21±3.13 765 9.18±3.08
Week 8 369 13.97±4.01 752 13.9±4.09
Week 24 372 14.77±4.25 747 14.7±4.20
Week 52 362 13.59±3.4 707 13.2±3.71
Ab response to vaccination
Pertussis (EU/ml)
Week 12 355 7.61 (6.77, 8.57)/69.3% 711 5.52 (5.04, 6.03)/50.1%
Week 24 322 132.37 (111.44, 157.22)/96.0% 663 89.81 (77.71, 103.79)/88.2%
Diphtheria (IU/ml)
Week 12 355 0.26 (0.22, 0.32)/72.4 % 711 0.12 (0.11, 0.14)/55.5%
Week 24 322 1.18 (1.04, 1.34)/94.1% 663 1.40 (1.30, 1.51)/96.8%
Tetanus (IU/ml)
Week 12 355 0.83 (0.75, 0.91)/98.9% 711 0.64 (0.59, 0.68)/97.3%
Week 24 322 4.34 (3.81, 4.94)/99.7% 663 3.71 (3.40, 4.05)/99.6%
Morbidity
Sum of 12 weeks 360 8.3±10.9 729 9.6±12.1
Sum of 24 weeks 361 18.7±18.3 730 22.8±23.5
International standards’ protective Ab titres (WHO): diphtheria and tetanus >0.1 IU/mL24 28; pertussis >5.0 EU/ml.27
*The (%) presented that the percentage of samples had protective Ab titres.
Ab, antibody; ENID, Early Nutrition and Immune Development; GM, geometric mean; TI, Thymic Index.
Figure 1 Aflatoxin- albumin level (log transformed) in rainy and dry seasons at 24 weeks and 52 weeks. Wk, week.
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at 24 weeks. For diphtheria, 72.4% of infants at 12 
weeks and 94.1% at 24 weeks showed protective levels. 
For tetanus, the rates were 98.9% and 99.7% between 
the two time points. Ab titres were slightly higher in 
samples collected during the rainy season at 12 weeks 
of age, but lower at 24 weeks of age (figure 3).
Primary outcomes of ENID trial versus ENID substudy
Table 2 compares the mean TI value and GM level of Ab 
titres in our AF substudy and the full ENID trial. Infants 
included in our substudy showed no significant differ-
ence in mean TI when compared with the overall 800 
infants in the ENID trial. In terms of the Ab response 
titres, except for the Ab response to diphtheria at 24 
weeks, both the GM of Ab titres and the percentage 
of samples with protective Ab titres were higher in the 
subgroup studied here than in the full cohort of ENID 
infants. However, morbidity was higher among the 
ENID trial subjects than in our subsamples at both 12 
weeks and 24 weeks.
AF exposure and primary outcomes
Figures 2 and 3 present the TI and Ab titre in the low 
and high AF- alb groups. The mean TI was lower in the 
high AF- alb group than in the low AF- alb group during 
the first 24 weeks, but the difference was only statisti-
cally significant at 8 weeks (mean: 14.9 cm3 vs 13.1 cm3, 
p<0.0001), and not present at 52 weeks (figure 2). 
There were no significant differences for Ab response 
to pertussis and tetanus vaccines between the low and 
high AF- alb groups (figure 3). However, a significantly 
higher Ab titre against diphtheria was determined in 
infants in the high AF- alb group compared with those 
in the low AF- alb group at both time points (Ab GM at 
week 12: 0.16 IU/mL vs 0.46 IU/mL, p<0.0001; Ab GM 
at week 24: 0.96 IU/mL vs 1.46 IU/mL, p=0.0011).
Figure 2 Thymic Index (TI) in children in low or high aflatoxin- albumin (AF- alb) groups or in different seasons. The low and 
high AF- alb groups were divided by the median level at each time point. TI at week 8, week 12 and week 24 were grouped by 
AF- alb at week 24 and TI at 52 weeks was grouped by AF- alb level at week 52. The season of TI was defined as the time of 
measurement conducted.
Figure 3 Antibody (Ab) level to vaccination in low or high aflatoxin- albumin (AF- alb) group and in different seasons. The low 
and high AF- alb groups were divided by the median level at week 24. The season of Ab level was defined as the date of blood 
sample collection. Wk, week.
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Regression analysis with or without adjusting for the 
other variables showed that there were no significant 
associations between AF- alb level and TI at 1 week, 24 
weeks or 52 weeks (table 3). However, significant nega-
tive correlations were determined between AF- alb and 
TI at 8 weeks in all unadjusted and adjusted models. 
In addition, the random effect model, which measured 
the AF- alb correlation with all time points of TI pooled 
data, also showed significantly negative correlations at 
24 weeks in both unadjusted and adjusted models, and 
at 52 weeks in adjusted models.
Regression analysis confirmed a significant positive 
correlation between AF exposure level and Ab response 
to diphtheria at both 12 weeks and 24 weeks of age 
(p<0.001 and p=0.002, respectively), but there were 
no significant associations between AF- alb level and Ab 
response to pertussis and tetanus (table 4).
Neither maternal nor infant supplementation had a 
significant effect on AF- alb level, TI or Ab titre at any 
time point (data not presented).
DISCUSSION
This is the first study to investigate the impact of AF expo-
sure on immune function of infants less than 12 months 
of age using TI and Ab response to DTP vaccination as 
Table 3 Relationship between AF- alb level and TI
Model 1 Model 2 Model 3
Coef. (SE) P value Coef. (SE) P value Coef. (SE) P value
Week 1 −0.0083 (0.018) 0.637 −0.0012 (0.018) 0.95 −0.0012 (0.018) 0.948
Week 8 −0.0606 (0.014) <0.001 −0.056 (0.014) <0.001 −0.056 (0.014) <0.001
Week 24 −0.0098 (0.014) 0.49 −0.015 (0.015) 0.3 −0.015 (0.015) 0.301
Week 52 −0.0115 (0.014) 0.399 −0.014 (0.014) 0.296 −0.014 (0.014) 0.301
All time points to infant age <24 
weeks
−0.027 (0.011) 0.014 −0.023 (0.010) 0.022 −0.023 (0.010) 0.021
All time points to infant age <52 
weeks
0.0076 (0.007) 0.28 −0.053 (0.007) <0.001 −0.052 (0.007) <0.001
TI at 1 week, 8 weeks and 24 weeks were analysed with AF- alb level at 24 weeks. TI at 52 weeks was analysed with AF- alb level at 52 
weeks.
Model 1 unadjusted.
Model 2 adjusted for infant size (length), sex and season at TI measurement.
Model 3 adjusted for infant size (length), season at TI measurement, sex and maternal supplement groups (for age ≤24 weeks) and 
infants supplement groups (for age at 52 weeks).
AF- alb, aflatoxin- albumin; Coef., coefficient; TI, Thymic Index.
Table 4 Relationship between AF- alb level and Ab response to vaccination
Model 1 Model 2 Model 3
Coef. (SE) p Coef. (SE) p Coef. (SE) p
Pertussis
Week 12 −0.093 (0.058) 0.11 −0.093 (0.060) 0.123 −0.088 (0.070) 0.207
Week 24 0.143 (0.083) 0.085 0.133 (0.086) 0.124 0.099 (0.096) 0.301
Fold change 0.190 (0.109) 0.083 0.197 (0.113) 0.084 0.127 (0.127) 0.319
Diphtheria
Week 12 0.421 (0.093) <0.001 0.418 (0.094) <0.001 0.495 (0.109) <0.001
Week 24 0.186 (0.058) 0.002 0.190 (0.061) 0.002 0.204 (0.064) 0.002
Fold change −0.239 (0.097) 0.014 −0.124 (0.097) 0.204 −0.149 (0.106) 0.162
Tetanus
Week 12 0.065 (0.048) 0.175 0.065 (0.049) 0.182 0.096 (0.056) 0.089
Week 24 −0.034 (0.062) 0.578 −0.064 (0.064) 0.322 −0.071 (0.070) 0.316
Fold change −0.111 (0.081) 0.172 −0.096 (0.084) 0.252 −0.127 (0.092) 0.168
Ab response to vaccination were analysed with AF- alb level at 24 weeks only.
Model 1 unadjusted.
Model 2 adjusted for WHZ and season of sample collection.
Model 3 adjusted for WHZ and season of sample collection, sex, maternal supplement group, Hb levels and morbidity.
Ab, antibody; AF- alb, aflatoxin- albumin; Coef., coefficient; Hb, haemoglobin; WHZ, weight for height z- score.
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indicators of immune function. Infants who were exposed 
to higher levels of AF had smaller thymus during the first 
24 weeks of age and had significantly higher protective 
Ab titres against diphtheria.
The observed high prevalence of AF exposure in the 
present study is consistent with previous findings in the 
same region of Gambia.5 31 32 It is worth noting that the 
ELISA method used in this study gives AF- alb values that 
are approximately threefold higher than AF lysine values 
measured by LC- MS methods but that results between 
methods correlate for the same samples.33 This issue was 
discussed by McMillan et al11 and needs to be taken into 
consideration when comparing values obtained using the 
different methods. An increasing prevalence and upward 
trend of AF- alb levels with age were determined in our 
study. Infants at 52 weeks showed more than sevenfold 
higher levels of AF- alb than at 24 weeks of age. AF expo-
sure could happen in utero through transplacental expo-
sure, and the exposure level will increase during the first 
year when infants are gradually introduced to comple-
mentary foods.2
The Gambia has pronounced dry and rainy seasons, and 
previous studies have shown a seasonal impact on both 
growth and AF exposure.6 34 In the present study, serum 
samples collected during the dry season had significantly 
higher levels of AF- alb than those samples collected during 
the rainy season. The annual dry season in the Gambia is 
a time of relative food availability, as food supplies from 
the previous harvest are usually plentiful. AF contamina-
tion in foods and crops tends to increase after a period 
of storage.35 Populations are more likely to consume old 
grains towards the end of the dry (harvest) season, and 
foods which have been stored for a period are more likely 
to be contaminated. Our findings are consistent with 
previous studies in Benin and Guinea.10 36 However, expo-
sure can also depend on food type. In Senegal, Watson et 
al found that higher AF- alb levels in the harvest season 
compared with the postharvest season correlated with the 
recorded high consumption (4 days or more days a week) 
of contaminated groundnuts during the harvest period, 
with groundnuts being more susceptible to contamina-
tion than maize.37
Similar growth trend and seasonal variation of TI were 
previously reported in the Gambia by Collinson et al who 
also reported the consistently smaller thymus size in the 
rainy season, and significant difference at 8 weeks of age 
(p=0.001).38 The significant retardation of thymus at 8 
weeks found in children with high AF exposure might 
be due to it the time point that the thymus grows fastest. 
The sonographic method used in the current study to 
assess TI only represents an anatomical feature and not 
function, but previous studies in animals and infants 
have demonstrated a correlation between thymus size 
and lymphocyte proportion and function.39 40 Therefore, 
smaller TI in infants could predict a lower immunity in 
the future. Previously, AF- induced damage on the thymus 
has only been investigated in animal models. A recent 
study reported that AF caused thymic histopathological 
lesions and pathological impairments in chickens, which 
had been fed with AF- contaminated feeds (34.3–134 µg 
AFB1/kg corn feed) for 21 days and 42 days.
40 The reduc-
tion in thymus size and number of apoptotic lymphocytes 
occurred in a dose- dependent manner.
There was no previous study investigating the influ-
ence of AF exposure on Ab response to DTP vaccination. 
In our study, we found a significant positive association 
between AF biomarker level and Ab titre to diphtheria. An 
earlier study conducted in Gambian infants determined a 
similar weak but significant positive correlation between 
AF- alb level and one serotype of anti- pneumococcal Ab.15 
An animal study to induce anti- AF B1 Ab in dairy cows, 
which combined AFB1 with recombinant diphtheria toxin 
molecules injected into heifers, boosted the generation 
of anti- AFB1 Abs.
41 The effect of AF on Ab response could 
vary depending on the feature of the vaccines, as early 
animal studies conducted in chicken and rabbits reported 
inverse influence of AF exposure level on Ab response to 
different vaccines.42 43 The mechanism behind the signifi-
cant positive correlation between AF- alb level and Ab titre 
to diphtheria needs further investigation.
One limitation of the current study was that the AF- alb 
levels were not measured at the birth of infants or in 
the maternal blood; so while the AF- alb biomarker inte-
grates exposure over the previous 2–3 months,44 AF- alb 
levels may not accurately reflect exposure in early weeks. 
However, Turner et al5 reported a close association of 
AF- alb levels in maternal and infants’ cord blood, and 
also reported a significant negative correlation between 
maternal AF biomarker level and child weight and height 
gain at the first year of life.5 In our study, we found that 
the TI was significantly correlated with the weight of 
infants in the first year. Considering the AF- associated 
growth retardation determined in infants in the current 
cohort,7 we suggest that AF could be a potential factor 
that influenced child growth and thymus development 
during the early stages of life.
A few previous studies have examined the effect of 
high levels of AF exposure on markers of immunity in 
human. Turner et al15 reported a decrease in expression 
of salivary IgA in children from rural Gambia with detect-
able AF- alb levels compared with those with undetectable 
levels.15 A lower percentage of T cells and B cells has 
been observed in participants with high concentrations 
of AF- alb in Ghanaians aged between 19 years old and 
86 years old.16 17 However, some animal studies of AF- in-
duced effects on the immune system are inconsistent: Li 
et al45 and Meissonnier et al46 found no significant effect 
of AFB1 on humoral immunity function in chickens and 
pigs.45 46 While another study found increased expression 
of IgM and IgG in pigs dosed with high AF- contaminated 
feed.47 The mechanism of the immunoglobulin rise is 
unclear.
In conclusion, we have demonstrated a significant 
effect of AF exposure on infant immune development, 
assessed by thymic size. Less consistent evidence was 
found for infants’ Ab response to vaccination. This study 
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adds to evidence that AF exposure in infants can modify 
the immune response, and further efforts should be 
made to ameliorate dietary AF exposure across popula-
tions in SSA.
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